Ribera A - Search Results

1

Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii.

Ribera A, Roca I, Ruiz J, Gibert I, Vila J. Ribera A, et al. J Antimicrob Chemother. 2003 Sep;52(3):477-80. doi: 10.1093/jac/dkg344. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888597

2

Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates.

Vila J, Ribera A, Marco F, Ruiz J, Mensa J, Chaves J, Hernandez G, Jimenez De Anta MT. Vila J, et al. Among authors: ribera a. J Antimicrob Chemother. 2002 Mar;49(3):471-7. doi: 10.1093/jac/49.3.471. J Antimicrob Chemother. 2002. PMID: 11864947

3

Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates.

Ribera A, Ruiz J, Jiminez de Anta MT, Vila J. Ribera A, et al. J Antimicrob Chemother. 2002 Apr;49(4):697-8. doi: 10.1093/jac/49.4.697. J Antimicrob Chemother. 2002. PMID: 11909848 No abstract available.

4

Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii.

Ribera A, Ruiz J, Vila J. Ribera A, et al. Antimicrob Agents Chemother. 2003 Jul;47(7):2310-2. doi: 10.1128/AAC.47.7.2310-2312.2003. Antimicrob Agents Chemother. 2003. PMID: 12821485 Free PMC article.

5

In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.

Ribera A, Jurado A, Ruiz J, Marco F, Del Valle O, Mensa J, Chaves J, Hernández G, Jiménez de Anta MT, Vila J. Ribera A, et al. Diagn Microbiol Infect Dis. 2002 Feb;42(2):123-8. doi: 10.1016/s0732-8893(01)00335-2. Diagn Microbiol Infect Dis. 2002. PMID: 11858908

6

High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.

Ruiz J, Gómez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J. Ruiz J, et al. Among authors: ribera a. Diagn Microbiol Infect Dis. 2002 Apr;42(4):257-61. doi: 10.1016/s0732-8893(01)00357-1. Diagn Microbiol Infect Dis. 2002. PMID: 12007443

7

Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates.

Ribera A, Doménech-Sanchez A, Ruiz J, Benedi VJ, Jimenez de Anta MT, Vila J. Ribera A, et al. Microb Drug Resist. 2002 Winter;8(4):245-51. doi: 10.1089/10766290260469499. Microb Drug Resist. 2002. PMID: 12523620

8

Molecular characterization of the gene encoding a new AmpC beta-lactamase in a clinical strain of acinetobacter genomic species 3.

Beceiro A, Dominguez L, Ribera A, Vila J, Molina F, Villanueva R, Eiros JM, Bou G. Beceiro A, et al. Among authors: ribera a. Antimicrob Agents Chemother. 2004 Apr;48(4):1374-8. doi: 10.1128/AAC.48.4.1374-1378.2004. Antimicrob Agents Chemother. 2004. PMID: 15047547 Free PMC article.

9

Evidence for a reserpine-affected mechanism of resistance to tetracycline in Neisseria gonorrhoeae.

Ruiz J, Ribera A, Jurado A, Marco F, Vila J. Ruiz J, et al. Among authors: ribera a. APMIS. 2005 Oct;113(10):670-4. doi: 10.1111/j.1600-0463.2005.apm_303.x. APMIS. 2005. PMID: 16309425

10

Nosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strain.

Rodriguez-Baño J, Martí S, Ribera A, Fernández-Cuenca F, Dijkshoorn L, Nemec A, Pujol M, Vila J. Rodriguez-Baño J, et al. Among authors: ribera a. J Clin Microbiol. 2006 Apr;44(4):1587-9. doi: 10.1128/JCM.44.4.1587-1589.2006. J Clin Microbiol. 2006. PMID: 16597902 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters